Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma

Blood (2019) 134 (Supplement_1): 4033.

https://doi.org/10.1182/blood-2019-124179

Published: 2019

Journal Articles

Radiation-Sparing Treatment of HIV-Related Primary Central Nervous System Lymphoma with Antiretroviral Therapy, Rituximab and High-Dose Methotrexate

Kathryn Lurain, MD MPH, Thomas S. Uldrick, MD MS, Priscila H. Goncalves, MD, Ramya Ramaswami, MBBS, MPH, Mark N. Polizzotto, Anaida Widell, Seth M. Steinberg, PhD, Elaine S. Jaffe, Stefania Pittaluga, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Constance M. Yuan, MD PhD, Richard F. Little, MD MPH, Robert Yarchoan, MD

Blood (2018) 132 (Supplement 1): 2963.

https://doi.org/10.1182/blood-2018-99-112169

Published: 2018

Journal Articles

Decreasing Dose and Duration of Dexamethasone Therapy for Low-Risk Childhood Acute Lymphoblastic Leukemia Aiming to Avoid Serious Viral Infections Results in Significant Increase in Isolated CNS Relapse: A Prospective Study

Khaled M Ghanem, MD, Miguel R Abboud, MD, Nidale Tarek, MD, Raya Saab, MD, Hani Tamim, PhD, Hassan El-Solh, MD, Samar A. Muwakkit, MD

Blood (2017) 130 (Supplement 1): 1284.

https://doi.org/10.1182/blood.V130.Suppl_1.1284.1284

Published: 2017

Journal Articles

Evaluation of Infectious Complications after Haploidentical Stem Cell Transplantation in Adult Patients with Hematologic Malignancies

Razan Mohty, Florent Malard, MDPhD, Annalisa Ruggeri, MD, Eolia Brissot, MDPhD, Remy Duléry, MD, Giorgia Battipaglia, MD, Frederica Giannotti, MD, Mohamad Mohty, MD PhD

Blood (2017) 130 (Supplement 1): 664.

https://doi.org/10.1182/blood.V130.Suppl_1.664.664

Published: 2017

Journal Articles

Most Closely HLA-Matched Third Party Allogeneic CMV Specific T-Cells Generated Using the Cytokine Capture System for the Treatment of CMV Infections after Allogeneic Stem Cell Transplantation

Blood (2016) 128 (22): 4547.

https://doi.org/10.1182/blood.V128.22.4547.4547

Published: 2016

Journal Articles

Long-Term Follow up of Patients with HIV-Associated Non-Hodgkin Lymphoma (NHL) after Autologous Stem Cell Transplantation (ASCT)

Liana Nikolaenko, MD, Saro Armenian, DO, MPH, Joseph C. Alvarnas, MD, John A. Zaia, MD, Leanne Goldstein, DrPH, Maria Viviana Marroquin, Amrita Y. Krishnan, MD

Blood (2016) 128 (22): 4614.

https://doi.org/10.1182/blood.V128.22.4614.4614

Published: 2016

Journal Articles

Safety and Preliminary Efficacy of "Ready to Administer" Cytomegalovirus (CMV)-Specific T Cells for the Treatment of Patients with Refractory CMV Infection

Ifigeneia Tzannou, MD, Kathryn S. Leung, Caridad Martinez, MD, Swati Naik, MD, Stephen Gottschalk, MD, Adrian P. Gee, PhD, Bambi Grilley, Ayumi Watanabe, Ann M. Leen, PhD, Sunitha Kakarla, PhD, Bilal Omer, MD

Blood (2016) 128 (22): 388.

https://doi.org/10.1182/blood.V128.22.388.388

Published: 2016

Journal Articles

Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma

Alexandra Albertsson-Lindblad, Arne Kolstad, Anna Laurell, Riikka Räty, Kirsten Grønbæk, Jan Sundberg, Lone Bredo Pedersen, Elisabeth Ralfkiær, Marja-Liisa Karjalainen-Lindsberg, Christer Sundström, Mats Ehinger, Christian Geisler, Mats Jerkeman

Blood (2016) 128 (14): 1814–1820.

https://doi.org/10.1182/blood-2016-03-704023

Published: 2016

Includes: Supplemental data

Journal Articles

Successful Treatment of Refractory CMV Chorioretinitis and Meningoencephalitis with Adoptive Transfer of Third Party CMVpp65 Specific T-Cell Lines

Susan Prockop, MD, Aisha Hasan, MD, Ekaterina Doubrovina, MD PhD, H.R. Castro-Malaspina, MD, Juliet N. Barker, MBBS(Hons), FRACP, Parastoo B Dahi, MD, Farid Boulad, MD, Nancy A. Kernan, MD, Guenther Koehne, MD PhD, Craig S. Sauter, MD, Szilard Kiss, MD, Mrinali Patel, MD, Stephanie Suser, BA, Richard J O'Reilly, MD

Blood (2015) 126 (23): 3157.

https://doi.org/10.1182/blood.V126.23.3157.3157

Published: 2015

Journal Articles

BPX-501 Cells (donor T cells transduced with iC9 suicide gene) Are Able to Clear Life-Threatening Viral Infections in Children with Primary Immune Deficiencies Given Alpha/Beta T-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (haplo-HSCT)

Barbarella Lucarelli, MD, Pietro Merli, MD, Alice Bertaina, MDPhD, Matilde Sinibaldi, PhD, Stefania Gaspari, MD, Luisa Strocchio, MD, Angela Pitisci, PhD, Giuseppina Li Pira, PhD, Giuseppe Maria Milano, MD, Annemarie Moseley, MDPhD, Concetta Quintarelli, PhD, Franco Locatelli, Prof, MD PhD

Blood (2015) 126 (23): 4299.

https://doi.org/10.1182/blood.V126.23.4299.4299

Published: 2015

Journal Articles

Anti CMV and/or Anti Adenovirus IFN-g-Positive CD4+ CD8+ T Lymphocytes for Treatment of Viral Infections After Allogeneic HSC Transplantation: First Results

Liliane Dal Cortivo, MD, RITA Creidy, PhD, Aurélie Gabrion, Marianne Leruez-Ville, Sebastien Heritier, MD, Fabien Touzot, MD, PhD, Guilhem Cros, MD, Sebastien Maury, MD, Alienor Xhaard, Marie Ouachee, MD, Ingrid Hamon, Tech, Capucine Picard, MD, PhD, Christophe Cambouris, Salima Hacein Bey Abina, PhD, Stephane Blanche, MD, Marina Cavazzana-Calvo, MD, PhD

Blood (2012) 120 (21): 1906.

https://doi.org/10.1182/blood.V120.21.1906.1906

Published: 2012

Journal Articles

Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CCR4 Antibody, in Patients with Relapsed Peripheral and Cutaneous T-Cell Lymphoma

Takashi Ishida, MD, PhD, Michinori Ogura, MD, PhD, Kiyohiko Hatake, Masafumi Taniwaki, MD, PhD, Kiyoshi Ando, MD, PhD, Kensei Tobinai, MD, PhD, Katsuya Fujimoto, MD, PhD, Kazuhito Yamamoto, M.D., Ph.D., Toshihiro Miyamoto, MD, PhD, Naokuni Uike, MD, PhD, Mitsune Tanimoto, MD, PhD, Kunihiro Tsukasaki, MD, PhD, Kenichi Ishizawa, MD, PhD, Junji Suzumiya, MD, PhD, Hiroshi Inagaki, MD, PhD, Kazuo Tamura, MD, PhD, Shiro Akinaga, PhD, Masao Tomonaga, MD, PhD, Ryuzo Ueda, MD, PhD

Blood (2012) 120 (21): 795.

https://doi.org/10.1182/blood.V120.21.795.795

Published: 2012

Journal Articles

Rituximab, Fludarabine and Alkylating Agents in Peripheral Neuropathies Related to IgM Monoclonal Gammopathy with Autoantibody Activity against Myelin-Associated-Glycoprotein : a Retrospective Study of 15 Patients.

Lionel Karlin, Bertrand Arnulf, Lionel Galicier, Bouchra Asli, Marion Malphettes, Claire Fieschi, Sophie Cereja, Eric Oksenhendler, Jean-Paul Fermand, Jean-Claude Brouet

Blood (2009) 114 (22): 3883.

https://doi.org/10.1182/blood.V114.22.3883.3883

Published: 2009

Journal Articles

A Single-Institution Randomized Prospective Trial of Pre-Emptive Therapy with Oral Valganciclovir Compared with IV Ganciclovir for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplant (aHSCT), Delayed until Viral Load (VL) >10,000 Copies/Ml or >5,000 Copies/Ml X 2

James C Mosley, III, M.D., Linda Verkruyse, MD, PhD, Mark Fiala, B.S., Kim Trinkhaus, Ph.D., Camille N Abboud, MD, Amanda F Cashen, MD, Geoffrey L. Uy, MD, Keith Stockerl-Goldstein, MD, Gregory A Storch, M.D., Peter Westervelt, MD, PhD, John F. DiPersio, MD, PhD, Ravi Vij, MD

Blood (2008) 112 (11): 4340.

https://doi.org/10.1182/blood.V112.11.4340.4340

Published: 2008

Journal Articles

Reduced Intensity Hematopoietic Stem Cell Transplantation for Treatment of Class 3 Lucarelli Severe Thalassemia Patients.

Suradej Hongeng, MD, Samart Pakakasama, MD, Ampaiwan Chuansumrit, MD, Nongnuch Sirachainan, MD, Thanyachai Sura, MD, Suporn Chancharunee, MD, Artit Ungkanont, MD, Saengsuree Jootar, MD

Blood (2006) 108 (11): 5364.

https://doi.org/10.1182/blood.V108.11.5364.5364

Published: 2006

Journal Articles

Safety of Cidofovir in High-Risk Paediatric Patients.

Vivek A. Bhadri, MA, MBBS, Lisa Lee-Horn, Med II, Peter J. Shaw, MA, MBBS, FRACP

Blood (2006) 108 (11): 5296.

https://doi.org/10.1182/blood.V108.11.5296.5296

Published: 2006

Journal Articles

Haploidentical Stem Cell Transplantation with CD3 Depleted Mobilized Peripheral Blood Stem Cell Grafts for Children with Hematologic Malignancies.

Gregory A. Hale, MD, Kimberly A. Kasow, DO, Kwan Gan, RN, Edwin Horwitz, MD, PhD, Joseph P. Woodard, MD, Usman Yusuf, MD, Raymond Barfield, MD, PhD, Wing H. Leung, MD, PhD, Deo K. Srivastava, PhD, Rupert Handgretinger, MD, PhD

Blood (2005) 106 (11): 2910.

https://doi.org/10.1182/blood.V106.11.2910.2910

Published: 2005

Journal Articles

Cidofovir: A Treatment for BK Virus Cystitis after Allogenic Bone Marrow Transplantation.

Katell Le Du, MD, Pierre-Simon Rohrlich, PhD, Fabrice Larosa, MD, Georges Herbein, PhD, Eric Deconinck, PhD

Blood (2005) 106 (11): 5354.

https://doi.org/10.1182/blood.V106.11.5354.5354

Published: 2005

Journal Articles

Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab

Stuart L. Goldberg, Andrew L. Pecora, Robert S. Alter, Mark S. Kroll, Scott D. Rowley, Stanley E. Waintraub, Kavita Imrit, Robert A. Preti

Blood (2002) 99 (4): 1486–1488.

https://doi.org/10.1182/blood.V99.4.1486

Published: 2002

NARROW

A Phase II, Multicenter Study of High Dose Chemotherapy with Autologous Stem Cell Transplant Followed By Maintenance Therapy with Romidepsin for T-Cell Lymphoma

Radiation-Sparing Treatment of HIV-Related Primary Central Nervous System Lymphoma with Antiretroviral Therapy, Rituximab and High-Dose Methotrexate

Decreasing Dose and Duration of Dexamethasone Therapy for Low-Risk Childhood Acute Lymphoblastic Leukemia Aiming to Avoid Serious Viral Infections Results in Significant Increase in Isolated CNS Relapse: A Prospective Study

Evaluation of Infectious Complications after Haploidentical Stem Cell Transplantation in Adult Patients with Hematologic Malignancies

Most Closely HLA-Matched Third Party Allogeneic CMV Specific T-Cells Generated Using the Cytokine Capture System for the Treatment of CMV Infections after Allogeneic Stem Cell Transplantation

Long-Term Follow up of Patients with HIV-Associated Non-Hodgkin Lymphoma (NHL) after Autologous Stem Cell Transplantation (ASCT)

Safety and Preliminary Efficacy of "Ready to Administer" Cytomegalovirus (CMV)-Specific T Cells for the Treatment of Patients with Refractory CMV Infection

Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma

Successful Treatment of Refractory CMV Chorioretinitis and Meningoencephalitis with Adoptive Transfer of Third Party CMVpp65 Specific T-Cell Lines

BPX-501 Cells (donor T cells transduced with iC9 suicide gene) Are Able to Clear Life-Threatening Viral Infections in Children with Primary Immune Deficiencies Given Alpha/Beta T-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (haplo-HSCT)

Anti CMV and/or Anti Adenovirus IFN-g-Positive CD4+ CD8+ T Lymphocytes for Treatment of Viral Infections After Allogeneic HSC Transplantation: First Results

Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CCR4 Antibody, in Patients with Relapsed Peripheral and Cutaneous T-Cell Lymphoma

Rituximab, Fludarabine and Alkylating Agents in Peripheral Neuropathies Related to IgM Monoclonal Gammopathy with Autoantibody Activity against Myelin-Associated-Glycoprotein : a Retrospective Study of 15 Patients.

A Single-Institution Randomized Prospective Trial of Pre-Emptive Therapy with Oral Valganciclovir Compared with IV Ganciclovir for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplant (aHSCT), Delayed until Viral Load (VL) >10,000 Copies/Ml or >5,000 Copies/Ml X 2

Reduced Intensity Hematopoietic Stem Cell Transplantation for Treatment of Class 3 Lucarelli Severe Thalassemia Patients.

Safety of Cidofovir in High-Risk Paediatric Patients.

Haploidentical Stem Cell Transplantation with CD3 Depleted Mobilized Peripheral Blood Stem Cell Grafts for Children with Hematologic Malignancies.

Cidofovir: A Treatment for BK Virus Cystitis after Allogenic Bone Marrow Transplantation.

Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only